DOMA intends to nominate three director candidates at Pacira annual meeting

1 hour ago 2

TipRanks

Wed, December 31, 2025 astatine 9:45 AM CST 1 min read

DOMA Perpetual Capital Management, which beneficially owns astir 6.83% of the outstanding shares of Common Stock of Pacira (PCRX) BioSciences, announced that it intends to nominate 3 autarkic manager candidates astatine the Company’s 2026 yearly gathering of stockholders. DOMA further asserts the Company’s Board of Directors should prosecute an contiguous merchantability of the Company. DOMA considers the existent level of Executive Compensation and General Spending to beryllium exorbitant and unmerited and questions whether the Board has exercised due fiduciary oversight.

Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions
Stay up of the marketplace with the latest quality and investigation and maximize your portfolio's potential

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See the apical stocks recommended by analysts >>

Read More connected PCRX:

Disclaimer & DisclosureReport an Issue

Pacira Ends Hip Osteoarthritis Injection Study for ZILRETTA: What Investors Should Know
Pacira joins PROBE Consortium
Pacira initiated with an Equal Weight astatine Barclays
Pacira reports inducement grants nether Nasdaq listing rule
Pacira announces results from 12-month aviator survey connected iovera

Read Entire Article